PubMed · 16145222
18F-FDG imaging: pitfalls and artifacts.
Abstract
18F-FDG PET is emerging as a useful tool in the staging and restaging of many malignant neoplasms, such as lymphoma, lung cancer, colorectal cancer, head and neck cancer, breast cancer, and melanoma. To accurately interpret 18F-FDG findings one must be familiar with the normal physiologic distribution of the tracer, frequently encountered physiologic variants, and benign pathologic causes of 18F-FDG uptake that can be confused with a malignant neoplasm. The objectives of this article are to (a) describe the mechanism of 18F-FDG uptake, (b) list the patient preparation and pertinent patient history before 18F-FDG imaging, (c) describe the whole-body physiologic distribution of 18F-FDG, (d) list and discuss normal physiologic variants, and (e) list and discuss benign pathologic causes of 18F-FDG uptake.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Mohei M Abouzied, Elpida S Crawford, Hani Abdel Nabi. 2005. 18F-FDG imaging: pitfalls and artifacts.. https://pubmed.ncbi.nlm.nih.gov/16145222/
Cite the original work for its findings. Save a collection to share your selection of sources.